Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study

Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study

Objective To evaluate the clinical and microbiological efficacy and safety of three doses of 3 g fosfomycin tromethamine administered orally to treat lower urinary tract infections.Design and participants This prospective, uncontrolled, open-label study was conducted in 12 medical centres in China,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shan Chen, Yong Yang, Bo Yang, Ming Chen, Kai Zhang, Yi Wang, Lu-Dong Qiao, Bo Zheng, Hong-Feng Guo, Yuan-Jie Niu, Ben-Kang Shi, Wei-Min Yang, Xiao-Kun Zhao, Xiao-Feng Gao
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2013-12-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/3/12/e004157.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections
by: George G. Zhanel, et al.
Published: (2020-01-01)

Revisiting fosfomycin to treat urinary tract infections in the era of rising carbapenem resistance
by: Sweety Kumari, et al.
Published: (2025-04-01)

Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario
by: Louise Perrault, et al.
Published: (2017-01-01)

Efficacy of high doses of intravenous fosfomycin for treatment of urinary tract infection caused by KPC carbapenemase-producing Klebsiella pneumoniae: An observational study
by: Jorge Rodríguez-Gómez, et al.
Published: (2025-03-01)

Comparison of the effectiveness of single-dose levofloxacin with single-dose fosfomycin pre-urodynamic study related to the incidence of urinary tract infection: a randomized controlled trial
by: Harrina Erlianti Rahardjo, et al.
Published: (2025-07-01)

Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections
by: Ayhanim Tumturk, et al.
Published: (2019-01-01)

Crystal structure and Hirshfeld surface analysis of ketorolac tromethamine
by: Anna M. Shaposhnyk, et al.
Published: (2025-05-01)

Intravenous Fosfomycin for Difficult-to-Treat Infections: A Real-Life Multicentric Study in Italy
by: Verena Zerbato, et al.
Published: (2025-04-01)

Evaluation of In-vitro Susceptibility of Multidrug-Resistant Urinary Escherichia Coli Isolates to Fosfomycin
by: Aleena Baby, et al.
Published: (2025-01-01)

Clinical utility of oral Nemonoxacin 500 mg once daily for the treatment of acute lower urinary tract infections: a prospective open-label, multicenter study
by: Zhen Du, et al.
Published: (2025-04-01)

Risk factors and prediction model construction of urinary tract infection in elderly patients with diabetic nephropathy
by: Cong Feng, et al.
Published: (2025-01-01)

Prevalence of Urinary Tract Infection and Antimicrobial Susceptibility among Diabetic Patients with Controlled and Uncontrolled Glycemia in Kuwait
by: May Sewify, et al.
Published: (2016-01-01)

Antimicrobial susceptibilities of clinical bacterial isolates from urinary tract infections to fosfomycin and comparator antibiotics determined by agar dilution method and automated micro broth dilution
by: Jamie L. Dombach, et al.
Published: (2025-03-01)

Thermal and Isothermal Methods in Development of Sustained Release Dosage Forms of Ketorolac Tromethamine
by: Dimple Chopra, et al.
Published: (2008-01-01)

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2020-04-01)

Staphylococcal Sepsis with Multiple Abscesses, Urinary Tract Infection, and Bilateral Renal Vein Thrombosis in a Patient with Uncontrolled Diabetes Mellitus
by: Malik A. A. Khan, et al.
Published: (2012-01-01)

Effect of topical ketorolac tromethamine and topical nepafenac on maintaining pupillary dilation during phacoemulsification
by: Richard Atanis, MD, et al.
Published: (2011-06-01)

Cisplatin‐induced nephrotoxicity and the protective effect of fosfomycin on it as demonstrated by using a crossover study of urinary metabolite levels
by: Masatoshi Hayashi, et al.
Published: (1997-06-01)

Effect of ketorolac tromethamine on pain management in patients with condyloma acuminata treated with 5-aminolevulinic acid photodynamic therapy
by: Xiaomeng Chen, et al.
Published: (2025-08-01)

Fosfomycin—Overcoming Problematic In Vitro Susceptibility Testing and Tricky Result Interpretation: Comparison of Three Fosfomycin Susceptibility Testing Methods
by: Jan Závora, et al.
Published: (2024-11-01)

Combination of Ketorolac Tromethamine and Prednisolone-Loaded PLGA Nanocomposite for Effective Chronic Pain Relief in Mice
by: Do TN, et al.
Published: (2025-06-01)

Effect of Perioperative Ketorolac Tromethamine and Acetaminophen Analgesia on the Outcome of Intestinal Anastomosis in a Rat Model
by: Mahmutaj Dafina, et al.
Published: (2025-03-01)

Scrub typhus with urinary tract infection and leukopenia: A case series
by: Cuiping Wu, et al.
Published: (2024-12-01)

Multicentre, randomised, open-label, phase IV–III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: study protocol for the SAFO trial
by: Joaquin López-contreras, et al.
Published: (2021-08-01)

Characterization of the gut microbiota in urinary calculi patients with preoperative urinary tract infection
by: Hao Chen, et al.
Published: (2025-02-01)

The immune mechanisms of the urinary tract against infections
by: Yilin Hou, et al.
Published: (2025-04-01)

Multidrug-Resistant Escherichia coli Causing Urinary Tract Infections among Controlled and Uncontrolled Type 2 Diabetic Patients at Laquintinie Hospital in Douala, Cameroon
by: Josiane Claire Sonkoue Lambou, et al.
Published: (2022-01-01)

Preparation of Carbopol 934 Based Ketorolac Tromethamine Buccal Mucoadhesive Film: In Vitro, Ex Vivo, and In Vivo Assessments
by: M. Yasmin Begum, et al.
Published: (2021-01-01)

URINARY TRACT INFECTION
by: A.N. Tsygin, et al.
Published: (2006-06-01)

Correlation of Preoperative Inflammation/Immunity Markers With Postoperative Urinary Tract Infections in Elderly Hip Fracture Patients
by: Xiao‐yang Liu, et al.
Published: (2025-08-01)

Enhanced efficacy of sequential administration of fosfomycin and linezolid against methicillin-resistant Staphylococcus aureus
by: Zaixing Chen, et al.
Published: (2025-03-01)

A multicenter, open-label and phase Ⅳ clinical study on the treatment of urinary tract infections with Relinqing granules
by: WANG Shusheng, et al.
Published: (2024-07-01)

Risk of urinary tract infection symptoms recurrence in women: A prospective observational study
by: Yi-Sheng Chen, et al.
Published: (2022-01-01)

Melanosis of the urinary bladder with associated urinary tract infection
by: Lauren Nesi, et al.
Published: (2025-03-01)

PENGARUH PEMBERIAN INJEKSI KETOROLAC TROMETHAMINE INTRAPERITONEAL TERHADAP GAMBARAN MIKROSKOPIS GASTER TIKUS WISTAR DEWASA DENGAN FRAKTUR KRURIS
by: Rifqi Raihan Haris, et al.
Published: (2016-11-01)

Urinary tract infections in children
by: Elzbieta Osuch, et al.
Published: (2018-01-01)

Urinary tract infections in women
by: Jacky van Schoor
Published: (2016-01-01)

Urinary tract infection and hyperbilirubinemia
by: Hülya Bilgen, et al.
Published: (2006-01-01)

URINARY TRACT INFECTION IN CHILDREN
by: T. V. Margieva, et al.
Published: (2014-07-01)

URINARY TRACT INFECTIONS IN CHILDREN
by: A.N. Tsygin
Published: (2010-11-01)